Show full item record
dc.contributor.author |
Goláň, Lubor |
pl |
dc.contributor.author |
Goker-Alpan, Ozlem |
pl |
dc.contributor.author |
Holida, Myrl |
pl |
dc.contributor.author |
Kantola, Ikka |
pl |
dc.contributor.author |
Klopotowski, Mariusz |
pl |
dc.contributor.author |
Kuusisto, Johanna |
pl |
dc.contributor.author |
Linhart, Aleš |
pl |
dc.contributor.author |
Musiał, Jacek [SAP20000227] |
pl |
dc.contributor.author |
Nicholls, Kathleen |
pl |
dc.contributor.author |
Gonzalez-Rodriguez, Derlis |
pl |
dc.contributor.author |
Sharma, Reena |
pl |
dc.contributor.author |
Vujkovac, Bojan |
pl |
dc.contributor.author |
Chang, Peter |
pl |
dc.contributor.author |
Wijatyk, Anna |
pl |
dc.date.accessioned |
2020-01-17T08:49:50Z |
|
dc.date.available |
2020-01-17T08:49:50Z |
|
dc.date.issued |
2015 |
pl |
dc.identifier.uri |
https://ruj.uj.edu.pl/xmlui/handle/item/136001 |
|
dc.language |
eng |
pl |
dc.rights |
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 3.0 |
* |
dc.rights.uri |
http://creativecommons.org/licenses/by-nc/3.0/legalcode |
* |
dc.title |
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease |
pl |
dc.type |
JournalArticle |
pl |
dc.description.physical |
3435-3444 |
pl |
dc.description.volume |
9 |
pl |
dc.description.points |
30 |
pl |
dc.identifier.doi |
10.2147/DDDT.S80928 |
pl |
dc.identifier.eissn |
1177-8881 |
|
dc.title.journal |
Drug Design, Development and Therapy |
pl |
dc.language.container |
eng |
pl |
dc.affiliation |
Wydział Lekarski : Klinika Alergii i Immunologii |
pl |
dc.subtype |
Article |
pl |
dc.rights.original |
CC-BY-NC; otwarte czasopismo; ostateczna wersja wydawcy; w momencie opublikowania; 0 |
pl |
dc.identifier.project |
ROD UJ / OP |
pl |
dc.cm.id |
73545 |
|
dc.cm.date |
2020-01-07 |
|
.pointsMNiSW |
[2015 A]: 30 |
|